Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.54 USD | -3.40% | +5.31% | -21.58% |
Business Summary
Number of employees: 13
Managers
Managers | Title | Age | Since |
---|---|---|---|
Enrique Poradosu
FOU | Founder | 58 | 27/20/27 |
Shay Shemesh
FOU | Founder | 41 | 27/20/27 |
Ronald Bentsur
CEO | Chief Executive Officer | 58 | 27/20/27 |
Michael Carson
DFI | Director of Finance/CFO | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Bentsur
CEO | Chief Executive Officer | 58 | 27/20/27 |
Matt Kaplan
BRD | Director/Board Member | 56 | 01/21/01 |
Kenneth Hoberman
BRD | Director/Board Member | 59 | 01/21/01 |
James Oliviero
BRD | Director/Board Member | 48 | 01/21/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,356,060 | 8,510,873 ( 46.37 %) | 0 | 46.37 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.58% | 12Cr | |
+15.55% | 12TCr | |
+12.66% | 11TCr | |
-2.53% | 2.48TCr | |
+1.28% | 2.25TCr | |
-9.58% | 1.83TCr | |
-42.28% | 1.63TCr | |
-18.92% | 1.53TCr | |
+6.19% | 1.41TCr | |
+28.83% | 1.17TCr |
- Stock Market
- Equities
- NVCT Stock
- Company Nuvectis Pharma, Inc.